跳至主要内容
临床试验/DRKS00000625
DRKS00000625已完成不适用

Prospective observational study to assess the efficacy and tolerability of Eptadone®, in heroin addicted patients undergoing a methadone maintenance treatment. - Metho.de

. Molteni & C. dei F.lli Alitti – Soc. di Esercizio S.p.A.0 个研究点目标入组 516 人开始时间: 2010年12月28日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
516

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18 Years 至 one(—)
性别
All

入选标准

  • (i) Both sexes;
  • (ii) Over 18 years of age;
  • (iii) Patients with a diagnosis of heroin addiction, according to ICD-10
  • (iv) Patients who starts or have started a maintenance treatment” with Eptadone®
  • (v) Accession to the observational study by informed consent.

排除标准

  • Patients with the following criteria will not be observed:
  • a) Inability to follow the observation, and to understand study procedures and follow them;
  • b) Diagnosis of:
  • (i) Decompensated psychotic disorders,
  • (ii) Epileptic attacks, not related with drug abuse,
  • (iii) Severe-acute or severe-chronic somatic diseases (like AIDS, Tubercolosis, acute hepatitis, Sepsis ecc.), whereas chronical HCV is not an exclusion criteria.

研究者

发起方
. Molteni & C. dei F.lli Alitti – Soc. di Esercizio S.p.A.

相似试验

Prospective observational study to assess the... | 临床试验